NCT07600320 · NOT YET RECRUITING
Fareon Open Label Device Clinical Trial
This trial is testing the Fareon device, a wearable at-home brain stimulation tool described as MMT (likely magnetic or electrical stimulation), in people with cognitive problems from brain injury, Long COVID, ME/CFS, or neurodegenerative conditions including Alzheimer's disease. The goal is to check whether the device is safe and practical to use at home, and to gather early data that could shape a larger future study. This is a Phase NA open-label feasibility trial — early-stage exploration, not a proven treatment.
Eligibility criteria
IncInclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Any sex/gender * 16 years of age or older * English Speaking * Experiencing symptoms of at least self-reported mild cognitive impairment associated with a confirmed diagnosis of a condition such as Long COVID, Traumatic Brain Injury, other Acquired Brain Injuries, and other neurodegenerative diagnoses including but not limited to Alzheimer's disease * Individuals of childbearing age agreeing to use a highly effective form of birth control for the duration of their participation * Willing and able to sign informed consent or have a parent or LAR able to sign informed consent form * Willing and able to attend all study visits virtually or in person Exclusion Criteria: Individual who meets any of the following criteria will be excluded from participation in this study: * Enrollment in another interventional clinical trial in the last 90 days or during the study period * Change in anti-depressant or other psychoactive medication or dose in the last 90 days * Cranially implanted devices or metal * Pacemaker * History of seizure disorder * Pregnant or plan to become pregnant during the study as indicated by proof of a positive pregnancy test * Inability to achieve appropriate positioning of the study device on the head * Any medical, psychiatric, or neurological condition, or concurrent treatment, that in the opinion of the Principal Investigator would interfere with study participation, interpretation of results, or pose additional risk to the participant.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-05-20